Fig. 1From: Human fetal mesenchymal stem cell secretome enhances bone consolidation in distraction osteogenesisSecretome from human fetal mesenchymal stem cells (hFMSCs) had more osteogenic potential and lower immunogenicity than that from rat bone marrow-derived mesenchymal stem cells (r BMSCs) and human adult mesenchymal stem cells (hAMSCs), as well as no effect on cell viability. a Both the alkaline phosphatase (ALP) staining and Alizarin Red S staining showed that more calcium deposits could be found after hFMSC secretome treatment. b The semi-quantitative results of Alizarin Red S staining demonstrated that significantly more mineralization was seen in the hFMSC secretome group. c Immunogenicity was determined by mixed rat peripheral blood lymphocyte reaction. The hFMSC secretome had no significant effect on rat peripheral blood lymphocyte proliferation. d Significant lymphocyte proliferation was stimulated after administration of hAMSC secretome. e Cell viability was evaluated by the MTT assay. The optical density (OD) level of rBMSCs treated with hFMSC secretome showed no significant difference among the doses from 10 μg/μl to 200 μg/μl. *p < 0.05, **p < 0.01. d daysBack to article page